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ABSTRACT Clostridium difficile is the cause of most frequently occurring nosocomial diarrhea worldwide. As an enteropatho-
gen, C. difficile must be exposed to multiple exogenous genetic elements in bacteriophage-rich gut communities. CRISPR (clus-
tered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated) systems allow bacteria to adapt to foreign ge-
netic invaders. Our recent data revealed active expression and processing of CRISPR RNAs frommultiple type I-B CRISPR
arrays in C. difficile reference strain 630. Here, we demonstrate active expression of CRISPR arrays in strain R20291, an epidemic
C. difficile strain. Through genome sequencing and host range analysis of several new C. difficile phages and plasmid conjuga-
tion experiments, we provide evidence of defensive function of the CRISPR-Cas system in both C. difficile strains. We further
demonstrate that C. difficile Cas proteins are capable of interference in a heterologous host, Escherichia coli. These data set the
stage for mechanistic and physiological analyses of CRISPR-Cas-mediated interactions of important global human pathogen
with its genetic parasites.
IMPORTANCE Clostridium difficile is the major cause of nosocomial infections associated with antibiotic therapy worldwide. To
survive in bacteriophage-rich gut communities, enteropathogens must develop efficient systems for defense against foreign DNA
elements. CRISPR-Cas systems have recently taken center stage among various anti-invader bacterial defense systems.We pro-
vide experimental evidence for the function of the C. difficile CRISPR system against plasmid DNA and bacteriophages. These
data demonstrate the original features of active C. difficile CRISPR system and bring important insights into the interactions of
this major enteropathogen with foreign DNA invaders during its infection cycle.
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Clostridium difficile is one of the major pathogenic clostridia.This Gram-positive, strictly anaerobic, spore-forming bacte-
rium is found in soil and aquatic environments and in mamma-
lian intestinal tracts. C. difficile became one of the key public
health problems in industrialized countries and one of the major
nosocomial enteropathogens. C. difficile-associated diarrhea is
currently the most frequently occurring nosocomial diarrhea in
Europe andworldwide (1, 2). Over the last decade, the proportion
of severe C. difficile infections has risen due to the emergence of
epidemic PCR ribotype 027 strains, such as the R20291 strain (3).
Twomajor risk factors for contractingC. difficile infections are the
age of the individual and exposure to antibiotics. Antibiotic ther-
apy causes alterations in the colonic microflora, allowing the de-
velopment ofC. difficile frompreexisting or acquired spores (4, 5).
The pathogen synthesizes two major toxins, TcdA and TcdB,
which glucosylate host GTPases, resulting in alterations in the
enterocyte cytoskeleton (6). This induces intestinal cell lysis and
inflammation, resulting in diarrhea, pseudomembranous colitis,
and even death (7). Many aspects of the C. difficile infection cycle,
including molecular mechanisms of its adaptation to changing
conditions still remain poorly understood (8, 9).
During its infection cycle, C. difficile survives within bacterio-
phage-rich gut communities and is therefore expected to possess
efficient systems to control genetic exchanges favored in such en-
vironments. The highly mobile and mosaic genome of C. difficile
(10) could reflect the continuous balance between the acquisition
of adaptive traits for gastrointestinal lifestyle and the efficient de-
fense against abundant invaders, such as phages andplasmids. The
CRISPR (clustered regularly interspaced short palindromic
repeats)-Cas (CRISPR-associated) systems are found in about half
of sequenced bacterial genomes and in almost all archaeal ge-
nomes and can provide defense against mobile genetic elements
(11, 12). CRISPR loci are arranged in arrays of almost identical
direct repeats of ~30 bp separated by similarly sized variable se-
quences called spacers. Some spacers match viral or plasmid DNA
andmust have been acquired during prior encounterswithmobile
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genetic elements in a process referred to as “adaptation.” A
CRISPR array is transcribed as a single RNA transcript (pre-
crRNA) that is processed to generate small CRISPR RNAs
(crRNAs), each containing one spacer and flanking repeat frag-
ments. These crRNAs, in complex with Cas proteins, serve as
guides to recognize foreign nucleic acids by complementary base
pairing. The recognition leads to degradation of targeted nucleic
acids, during a process referred to as “interference,” thus protect-
ing cells from invasion by foreign genetic elements.
The cas gene clusters are often associated with CRISPR arrays,
and the Cas proteins are involved in all stages of CRISPR-Cas
activity (13). According to the analysis of cas gene sets, the most
recent classification defines three major types of CRISPR-Cas sys-
tems (types I, II, and III) that can be further divided into 12 sub-
types (14, 15). Cas1 and Cas2 proteins required for the adaptation
step are universal components of all CRISPR-Cas systems. En-
doribonucleases of the Cas6 family in type I and type III systems
cleave the pre-crRNA, while RNase III is required for crRNA pro-
cessing in type II systems. For the interference step,mature crRNA
is boundby aCas protein complex known asCascade (cas complex
for antiviral defense) in type I systems or a distinct multisubunit
complex in type III systems, whereas type II systems use a single
Cas9 protein (16). Type I systems rely on an additional Cas3 pro-
tein for the degradation of foreign DNA. The important determi-
nants for self/nonself discrimination by type I and type II systems
are the protospacer-adjacent motifs (PAMs). PAMs are located
either at the 3= or 5= end of the protospacer (a fragment of invader
DNA that was earlier acquired as a spacer into CRISPR arrays)
(16).
The type I CRISPR-Cas systems are the most diverse and
have been classified into subtypes. Archaea contain mainly sub-
types I-A, I-B, and I-D, whereas bacteria contain mainly subtypes
I-C, I-E, and I-F (14). In contrast to several detailed studies of
representatives of subtypes I-A, I-C, and I-E, comparatively little
is known about subtypes I-B and I-D. The subtype I-B CRISPR-
Cas system is found in clostridia as well as in methanogenic and
halophilic archaea and is defined by a subtype-specific protein
Cas8b. The analysis of active haloarchaeal subtype I-B systems
revealed several distinct features, including multiple PAMs and
9-nucleotide (nt) noncontiguous seed regions for target DNA rec-
ognition (17–19). The experimental evidence for the role of Cas8
protein from archaeal subtype I-B system in Cascade targeting to
invader DNA has been recently reported (20). Bacterial subtype
I-B systems remain less characterized. On the one hand, the pos-
sibility of CRISPR-Cas system acquisition by horizontal gene
transfer from Archaea has been suggested for some clostridial
strains (21, 22). On the other hand, recent characterization of
crRNA processing by Cas6b endonuclease in Clostridium thermo-
cellum (22) and results of analysis of CRISPR systems in industri-
ally relevant clostridia (23) are in good agreement with the data
obtained for other type I subtypes, suggesting that at least some
haloarchaeal subtype I-B systems features may be specific to this
ecological group with its long-term independent evolution.
Our recent deep sequencing and Northern blot analysis re-
vealed the active expression of crRNA from multiple subtype I-B
CRISPR arrays in C. difficile reference strain 630, including some
located within prophage regions (24). In the present study, we
show by transcriptome sequencing (RNA-seq) analysis that nine
CRISPR arrays are also actively transcribed in the PCR ribotype
027 epidemic C. difficile strain R20291. To demonstrate the func-
tionality of this CRISPR system inC. difficile, we compared spacers
of C. difficile strain 630 and epidemic R20291 strains to phage
sequences, including several newly sequenced C. difficile phages,
and determined the host range for phages harboring sequences
matching spacers. A survey of occurrence and cas operon struc-
tures in published C. difficile genomes and extended spacer ho-
mology search in nine C. difficile strains suggested that the C. dif-
ficile CRISPR-Cas system has extensive potential for targeting of
phage and prophage genes. The functionality of the C. difficile
CRISPR-Cas system and the predicted 5= CCW PAM could be
directly demonstrated using plasmid conjugation efficiency assays
in C. difficile and interference assay in a heterologous Esche-
richia coli host.
RESULTS
Identificationof actively expressedCRISPRarrays inC.difficile.
Comparative analysis of subtype I-B CRISPR-Cas systems in the
C. difficile reference strain 630 and the PCR ribotype 027 epidemic
strain R20291 was performed. According to the CRISPRdb data-
base, C. difficile strain 630 carries genes that encode 12 potential
CRISPR arrays, 5 of which are located within prophage regions
(Fig. 1; see Table S1 in the supplemental material) (11). For fur-
ther reference, we used the CRISPRdb numbering for the C. diffi-
cile strain 630 CRISPR arrays and numbered spacers within each
array according to the identified transcriptional order. All 12 ar-
rays are actively expressed and processed into crRNA under labo-
ratory conditions (24) (see Fig. S1 in the supplemental material).
The distribution of CRISPR arrays throughout the chromosome
and their orientation appear to be nonrandom (Fig. 1A). CRISPR
3/4, 6, 7, 8, and 9 are transcribed from one DNA strand in the
clockwise direction, and CRISPR 10, 11, 12, 15/16, 17 are tran-
scribed from a different strand in the counterclockwise direction.
The cas gene clusterCD2982-CD2975 encoding Cas1 to Cas8 pro-
teins is located near the CRISPR 17 array. An additional incom-
plete cas operon CD2455-CD2451 lacking the universal cas1 com-
ponent as well as the cas2 and cas4 genes (Fig. 1B) is found close to
the CRISPR 12 array (Fig. 1A). Both cas operons are transcribed
according to our RNA-seq data.
In the epidemic R20291 strain, CRISPRdb predicted 13
CRISPR arrays. Four of the CRISPR arrays are located within the
tcdA toxin-encoding gene and contain a 24-bp repeat different
from the 29-bp repeat present in reference strain 630 arrays and in
the remaining strain R20291 arrays. To investigate the expression
of predicted R20291 arrays, we extracted RNA from cultures at
late exponential phase and subjected it to RNA-seq analysis. Ac-
tive expression of 9 CRISPR arrays carrying the 29-bp direct re-
peats was detected (Fig. 1A; see Fig. S2 in the supplemental mate-
rial). The highest level of expression was observed for the CRISPR
11, 13, 15, and 16 arrays (Fig. S2). Similar to our previous results
obtained with strain 630 (24) (Fig. S1) and in agreement with the
data from other bacterial systems (22, 25), the most-abundant
sequence reads mapped to leader-proximal regions (Fig. S2).
CRISPR “leader” is defined as the region between the transcrip-
tional start site (TSS) and the first repeat of CRISPR arrays. Some
genomic sequences coding for proteins containing repetitive mo-
tifs may erroneously be considered CRISPR arrays. However, the
transcription profiles for such regions and sequence analysis of
putative spacers can disprove the prediction. As described in Ma-
terials and Methods, we concluded from our RNA-seq data and
bioinformatics analysis that predicted arrays with 24-bp repeats
Boudry et al.
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within the tcdA gene are not real CRISPR arrays, and they were
excluded from further analysis.
Several CRISPR arrays are located in prophages in both C. dif-
ficile strains. In strain 630, CRISPR 6 is located within the skin
element, and CRISPR 3/4 and CRISPR 15/16 are located within
the homologous phiCD630-1 and phiCD630-2 prophages, re-
spectively. The CRISPR 3/4 and CRISPR 15/16 arrays are identical
to each other, and each appear to constitute a single array, i.e., are
cotranscribed (24). These duplicated arrays are parts of larger du-
plicated regions corresponding to phiCD630-1 and phiCD630-2
prophages (Fig. 1A). Likewise, in the R20291 strain, CRISPR 10 is
located within the skin element, and CRISPR 13 and CRISPR 14
arrays are located within the phi027 prophage (Fig. 1A). Similarly
to strain 630, one complete R20291 subtype I-B cas operon
CDR20291_2817-CDR20291_2810 (CDR20291_2817-2810) is lo-
cated near the CRISPR 19 array. The partial operon CDR20291_
2348-2344 homologous to the CD2455-CD2451 operon in strain
630 is not associatedwith aCRISPR array. An additional divergent
CDR20291_2998-2994 operon is associated with CRISPR 20 and
also lacks cas1, cas2, and cas4 (Fig. 1A and B). Expression of all
three operons is detected by RNA-seq analysis.
Our recent TSSmapping experiment in strain 630 revealed the
presence of 170- to 200-nt transcribed 5= “leader” regions (24)
(see Fig. S1 in the supplemental material). The alignment of
expressed CRISPR loci in strain 630 revealed conserved leader
elements immediately upstream of the first repeat (Fig. 2). In ad-
dition, upstream of the TSS, consensus elements of sigma
A-dependent promoters could be identified (Fig. 2). These func-
tional elements are also conserved for the expressed CRISPR ar-
rays from strain R20291 (data not shown).
A total of 119 29-bp repeat sequences were collected from the
expressed CRISPR loci of strain 630, and aligning these sequences
allowed us to establish a consensus sequence shown in Fig. 3A. A
total of 105 29-bp repeat sequences were collected from the
CRISPR loci expressed in strain R20291 with a consensus se-
quence similar to that for the strain 630CRISPR repeats. For some
CRISPR arrays in both strains, the leader-distal repeats had a vari-
ant sequence that was different from the rest of repeats. The over-
all high sequence conservation among direct repeats suggests that
the same set of Cas proteins processes all expressed pre-crRNAs in
strains 630 and R20291. Analysis of repeat consensus sequence
using Mfold suggests that in RNA this sequence could form a
FIG 1 Positions of CRISPR-Cas I-B loci inC. difficile strains 630 and R20291. (A) Schematic view of the genomic locations of expressed CRISPR arrays in strains
630 and R20291. CRISPR arrays (CR) are numbered according to the CRISPRdb database. Arrowheads indicate the array position, and transcriptional
orientation is indicated by colors as follows: green for the plus or coding strand and blue for the minus or noncoding strand. The locations of associated cas
operons, prophage regions, and replication origin (ori) are indicated. The right and left replichores are shown by black arrowheads. (B) Organization of the
operons for the complete (CD2982-CD2975) and partial cas operon (CD2455-CD2451) fromC. difficile strain 630 (left) and for the complete (CDR20291_2817-
2810) andpartial casoperons (CDR20291_2348-2344 andCDR20291_2998-2994) fromC. difficile strainR20291 (right). The same colorwas used for homologous
cas genes.
C. difﬁcile CRISPR System
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characteristic stem-loop secondary structure similar to the pre-
dicted structures for repeats from other subtype I-B CRISPR-Cas
systems (Fig. 3B) (17, 22, 23, 26).
Within 12 CRISPR arrays expressed in strain 630, 107 spacers
(98 unique spacers) with an average length of 37 bp (individual
spacers range from 35 to 39 bp) were identified. The number of
spacers ranges from three inCRISPR 4 andCRISPR 15 to nineteen
in CRISPR 17 (see Table S1 in the supplemental material). In
strain R20291, 96 spacers were identified within nine expressed
CRISPR arrays with lengths ranging from 33 to 41 bp (37-bp av-
erage length). The number of spacers ranged from four inCRISPR
12 to twenty-six in CRISPR 19 (Table S1). In both the 630 and
R20291 strains, the complete cas operons (CD2982-CD2975 and
CDR20291_2817-CDR20291_2810) are associated with a CRISPR
array containing the largest number of spacers. This may suggest
that the longest arrays created by numerous spacer acquisition
events and coexpressed with a complete functional set of cas genes
might constitute an active CRISPR functional unit within the bac-
terial genome. We can hypothesize that other CRISPR arrays
could use the same set of cas genes for functioning.
In silico analysis of C. difficile CRISPR system targeting. (i)
Phage genome sequencing. To identify sequences targeted by
C. difficile CRISPR spacers, we performed a systematic search for
sequence similarities in the NCBI database using BLASTN (27)
and the CRISPRTarget program (28). The search showed that
some C. difficile spacers matched known clostridial phage se-
quences. However, because of the limited number of available
genome sequences from clostridial phages, we set up a C. difficile-
specific phage sequencing project. For this parallel study, 10 dif-
ferent temperate phages isolated fromhuman and animal samples
and belonging to the Myoviridae or Siphoviridae family were se-
lected (29). Among newMyoviridae phages, the genome sequence
of phiCD481-1 was found to be similar to the previously pub-
lished phiCDHM13 and phiCDHM14 genomes (30), and to a
lesser extent to the phiCD506 and phiMMP04 genomes, while the
genome sequence of phiCD505 phage was similar to the genome
sequence of phiMMP02 (31); the phiMMP01 phage is highly sim-
ilar to phiMMP03, while the phiMMP03 phage is related to phiC2
(32). Among three new Siphoviridae phages, the genome se-
quences of phiCD111 and phiCD146 are highly similar to the
previously characterized phiCD38-2 (33). The phiCD24-1 ge-
nome sequence is unique.
(ii)C. difficileCRISPR spacer homology analysis.At the time
of this writing, the total number of available clostridial phage ge-
nome sequences is 22.We performed extensive homology analysis
of 819 CRISPR spacers from the available genome sequences of
nineC. difficile strains. Four strains of PCR ribotype 027 andmul-
tilocus sequence type 3 (MLST 3) (strains 2007855, BI1, CD196,
and R20291) have similar spacer contents, reflecting their evolu-
tionary relationships (see Fig. S3 in the supplemental material).
FIG 2 Alignment of CRISPR regions from C. difficile strain 630. The sequences of 10 independent CRISPR arrays (CR) numbered according to the CRISPRdb
database were aligned using the CLUSTALW program, and the upstream part of the alignment is shown. The names of the highly expressed arrays are shown in
red. The positions of TSS “1” identified by 5=-end RNA-seq are highlighted inmagenta (24). The potential35 and10 promoter elements corresponding to
sigma A-dependent consensus sequences are indicated by blue and green background, respectively. Direct repeats (DR) are highlighted in yellow and are
numbered according to the transcriptional order (DR1, DR2). The sequences of the first spacer (Spacer 1) from each array and a conserved leader motif are
indicated by a solid red line and broken black line, respectively. The region used for artificial CRISPR array engineering in the E. coli chromosome is delimited
by short black vertical arrows.
Boudry et al.
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The presence of three unique spacers was detected in the R20291
CRISPR arrays compared to the spacers from three other PCR
ribotype 027 strains. The CF5 and M68 strains of PCR ribotype
017 belonging to different MLST groups shared several CRISPR
spacers but differed greatly in the spacer number within their
CRISPR arrays. TheM68 strain shows the lowest number of spac-
ers (27 spacers) among analyzed strains. Some nearly identical
CRISPR arrayswere found in differentC. difficile strains, while BI9
andM120 strains possess uniqueCRISPR arrays (Fig. S3). Overall,
this analysis revealed several spacer deletion and acquisition
events, suggesting that dynamic changes in the CRISPR array con-
tent had occurred, possibly through interactions with foreign
DNA elements.
More than one-third of all analyzed spacers targeted the Clos-
tridium phages, and about half of the hits to the Clostridium chro-
mosome corresponded to the prophage regions (Fig. 4; see Ta-
ble S2A in the supplemental material). For example, among 66
spacers from strain CF5, 29 matched chromosome sequences of
which 17were fromprophages. These observations suggest that all
the C. difficile strains analyzed had intensive interactions with
phages. We also detected hits to Clostridium plasmids especially
for CRISPR spacers from strain M120. Interestingly, this strain of
PCR ribotype 078 possesses the largest number of unique spacers
(153 spacers) that extensively target foreign DNA elements and
are distributed in the six CRISPR arrays (Fig. 4, Fig. S3, and Ta-
ble S2A).
We next evaluated the potential functionality of CRISPR spac-
ers of strains 630 and R20291 targeting phages. Perfect and imper-
fect matches to phage or plasmid sequences were found for 39
spacers (36% of the total number of spacers) of strain 630 and for
38 spacers (40%) of strain R20291. Seventeen spacers from strain
630 and ten spacers from strain R20291 perfectly matched the
foreign DNA sequences, while remaining spacers contained be-
tween 1 and 10 mismatches with the targeted sequences (Table 1;
see Table S3 in the supplemental material). Remarkably, for each
CRISPR array from both analyzed strains, we found at least one
spacer targeting a clostridial phage sequence (Fig. 4), arguing in
favor of the functionality of each of the numerous C. difficile
CRISPR arrays. Previous studies ofCRISPR interference efficiency
inEscherichia coli,Pseudomonas aeruginosa, andHaloferax volcanii
carrying subtype I-E, I-F, and I-B CRISPR-Cas systems, respec-
tively, identified the sequence requirements for the CRISPR tar-
geting, in particular, a perfect match between the 5= end of the
spacer and the targetDNAprotospacerwithin up to a 10-nt “seed”
sequence. A single mismatch at position 6 and up to five mis-
matches outside the “seed” are tolerated without an apparent de-
crease in the interference efficiency (26, 34, 35). We analyzed the
locations of mismatches between the C. difficile CRISPR spacers
and the targeted protospacers. Spacers without mismatches in the
potential “seed” region (first 8 nt of the protospacer except for
position 6) and carrying up to five mismatches outside the “seed”
region were considered functional. In this way, six additional
FIG 3 C. difficile strain 630 CRISPR repeat consensus sequence in comparison with other CRISPR-Cas I-B systems. (A) The 29-bp direct repeats from all
expressed CRISPR arrays of strain 630 were aligned, and a consensus sequence was established on the basis of this alignment using WebLogo (http://we-
blogo.berkeley.edu). A consensus repeat sequence for subtype I-B CRISPR-Cas systems is shown below the WebLogo sequence and was determined by the
method in reference 16 (Rmeans A orG). (B) Predicted RNA secondary structure for repeat sequence ofC. difficile strain 630 compared to other repeat sequences
for subtype I-B CRISPR-Cas systems (17, 22, 23, 26). The RNA secondary structure was predicted using the Mfold software (66). The proposed position of
pre-crRNA cleavage by the Cas6 protein that generates the 8-nt 5= tag of crRNA during processing is indicated.
C. difﬁcile CRISPR System
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spacers with permissive mismatches were identified in CRISPR
arrays from each strain (Table 1 and Table S3), raising the propor-
tion of potentially functional CRISPR spacers matching the for-
eign DNA sequences to 59% and 42% in strains 630 and R20291,
respectively.
(iii) Nature and distribution of CRISPR-targeted genes.
CRISPR spacer homology analysis identified a total of 676 hits to
clostridial phage genome sequences with about 40 hits per phage
distributed throughout the genome on bothDNA strands (Fig. 5).
Themost “popular” were phiCD38-2 among siphophages with 54
hits and phiMMP04 among myophages with 42 hits. The
phiCD24-1 phage contained the lowest number of CRISPR spacer
hits (two hits). Interestingly, this analysis revealed several spacers
simultaneously targeting the related phage genomes (Fig. 5; see
Table S3 in the supplemental material). The majority of potential
protospacers were found within genes encoding structural pro-
teins with tail tape measure and capsid protein-encoding genes
being most frequently targeted (Table S2B and Table S3). Proto-
spacers were also present within genes of unknown function and
in intergenic regions (Table S3).Multiple targeting is observed for
theCRISPR spacers fromall analyzedC. difficile strains (Table S2C
and Table S3) and could provide C. difficile with an efficient and
economical defense against several related phages by the same
crRNA.
(iv) Identification of PAM. Conserved sequence motifs
(PAMs) in the regions flanking the protospacer were shown to be
important for the recognition by type I and II CRISPR-Cas sys-
tems (12). The alignment of phage sequences flanking protospac-
ers targeted by theC. difficileCRISPR system revealed a conserved
3-nucleotide 5= PAMmotif CCT orCCA (Fig. 6A) and nomotif in
the region downstreamof protospacers. This conserved 5=motif is
in accordance with the putative PAM sequences identified in the
previous in silico analyses (30) and is characteristic of subtype I-B
bacterial CRISPR-Cas systems (16) but differs from PAMs recog-
nized by the haloarchaeal subtype I-B CRISPR-Cas systems (26).
Among the alternativemotifs, CCC,CCG, andTCA trinucleotides
were detected most frequently. In particular, the TCA motif is
associated with the majority of protospacers targeted by strain
M120 CRISPR 8 spacers (see Table S2B in the supplemental ma-
terial).
Functionality of the C. difficile CRISPR system for interfer-
ence. (i) Analysis of plasmid conjugation efficiency.We next set
out to investigate the functional importance of the 5= CCW
3-nucleotide PAM. For this purpose, we compared the conjuga-
tion efficiencies of artificial plasmids containing different nucleo-
tides upstreamof the protospacer corresponding to the first spacer
within the strain 630 CRISPR 12 array. Plasmids pDIA5989 and
pDIA5990 carrying the CCA or CCT PAM upstream of the pro-
tospacer did not give any transconjugants. In contrast, the re-
placement of PAM by a GAG trinucleotide in pDIA5991 or an
AAT trinucleotide in pDIA5999 corresponding to the 3= end of
CRISPR repeat led to efficient conjugation (Fig. 6B).
It was recently reported that the sequence of protospacer and
the nature of the plasmid used for conjugation can influence the
CRISPR-mediated interference process (19). We prepared con-
structs derived from the pRPF185 vector carrying the same pCD6
Gram-positive bacterial replicon but a different Gram-negative
bacterial replicon and used them to monitor the plasmid DNA
targeting by another CRISPR spacer. In agreementwith the results
for the pDIA5989 plasmid, no transconjugants were obtained
with the pDIA6365 plasmid carrying a CCA PAMupstream of the
protospacer corresponding to the first spacer within the CRISPR
16 array from strain 630. Detectable conjugation was observed
with the pDIA6367 plasmid carrying the same protospacer mu-
tated at the first position within the potential “seed” region. How-
ever, this mutation did not completely abolish the interference
compared to the control pDIA6103 plasmid (Fig. 6B). Overall,
these results provide the first experimental evidence that the
C. difficile CRISPR-Cas system is naturally capable of interfering
with horizontal gene transfer and confirm the importance of the
PAM region for targeting foreign DNA.
(ii) Comparison of predicted CRISPR-mediated resistance
and susceptibility to phage infection. To assess the ability of the
C. difficile CRISPR-Cas system to interfere with phage infection,
we analyzed the correlation between the phage susceptibility pro-
files and theCRISPR spacer homology to the corresponding phage
sequences. Generally, the presence of a spacer matching the in-
coming phage DNA is expected to contribute to the resistance to
infection by the corresponding phage provided that a CRISPR-
Cas system is functional. In contrast, in the absence of an exact
match, the host cell should be phage sensitive.
We deduced the expected phage susceptibility phenotypes of
strains 630 and R20291 on the basis of the following criteria. We
checked for the following: (i) the presence of CRISPR spacers
exactly matching the corresponding phage sequences or carrying
only the allowed mismatches in position 6 of the potential “seed”
region or up to five mismatches outside the “seed” (the first 8
nucleotides of the protospacer) and (ii) the presence of a CCW 5=
PAM. If several spacers targeted the same phage, the number of
leader-proximal spacers meeting the above criteria was consid-
ered. The different interference efficiencies of spacers according to
their position with respect to the leader region were suggested in
previous studies and are likely caused by different abundance,
stability, and/or processing efficiency of the corresponding crRNA
(26, 36). To compare the predicted phage susceptibility phenotype
with the experimental results, we performed phage infection as-
says with strains 630 and R20291 and phages available to us. In
addition, we used our recently reported data on the host range
analysis for some newly described temperate phages infecting
C. difficile (29).
The results of this comparative analysis are summarized in Ta-
ble 1, and the complete data set is presented in Table S3 in the
supplemental material. Overall, a good correlation between the
presence of CRISPR spacer-targeting phage sequences and the
corresponding phage susceptibility phenotype was observed. The
genome ofC. difficile strain 630 carries the spacers targeting nearly
all isolated clostridial phages identified thus far. Accordingly, this
strain was resistant to all tested phages (Table 1; see Table S3 in the
FIG 4 Spacer homology analysis of CRISPR arrays for nine C. difficile strains. The spacer content of each CRISPR array is shown. The names of CRISPR arrays
transcribed on the plus orminus strand are shown on green and red, respectively. The same number was assigned to identical spacers within CRISPR arrays from
different strains. Color was used to show the spacermatching the clostridial phage genome sequence (red), plasmid (dark green), chromosomal prophage region
(yellow), other chromosomal region (light green), chromosome andphage or plasmid (taupe), both phage andplasmid (blue), phage andprophage (mauve), and
three groups (chromosome, plasmid, and phage0 (gray). Potential spacer deletion events are shown in bold type.
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TABLE 1 Phage sensitivity of C. difficile strains compared to CRISPR spacer homology to phage protospacers
Phage Strain
No. of spacers with exact
or allowed matcha PAMb
Expected phage
sensitivity
Experimental phage
sensitivityc
phiCD27 630 8 (6 leader-proximal) CCT/A Expected resistant Resistant
R20291 2 CCA/T Expected resistant Resistant
phiC2 630 2 CCA Expected resistant ND
630 1 ACA
R20291 2 CCA/T Expected resistant ND
phiCD38-2 630 3 CCA Expected resistant Resistant
630 1 TCC
R20291 3 (leader-distal) CCA Possibly sensitive Sensitive (29)
phiCD119 630 1 ACA Expected sensitive ND
R20291 1 CCA Expected resistant ND
phiCD6356 630 2 CCA/T Expected resistant ND
R20291 4 CCA/T Expected resistant ND
phiMMP01 630 3 CCA/T Expected resistant Resistant
R20291 1 CCA Expected resistant Resistant (29)
phiMMP03 630 2 CCA Expected resistant Resistant
630 1 ACA
R20291 2 CCA/T Expected resistant Resistant (29)
phiCD24-1 630 0 Expected sensitive Resistantd
R20291 0 Expected sensitive Resistantd
phiCD52 630 0 Expected sensitive Resistantd
R20291 2 CCA/T Expected resistant Resistant (29)
phiCD111 630 3 CCA Expected resistant Resistant
630 1 TCC
R20291 1 CCC Expected sensitive Resistantd (29)
phiCD146 630 3 CCA Expected resistant Resistant
630 1 TCC
R20291 2 (leader-distal) CCA Possibly sensitive Sensitive (29)
R20291 1 CTT
phiCD211 630 4 CCT/A Expected resistant Resistant
R20291 1 GCT Expected sensitive Resistantd
phiCD481-1 630 1 TCG Expected sensitive Resistantd
R20291 1 CCG Expected sensitive Sensitive (29)
phiCD505 630 5 (4 leader-proximal) CCA/T Expected resistant Resistant
R20291 3 CCA/T Expected resistant Resistant (29)
phiCD506 630 1 CCA Expected resistant Resistant
630 1 CCG
R20291 1 CCG Expected sensitive Resistantd (29)
phiMMP02 630 5 (leader-proximal) CCT/A Expected resistant Resistant
630 1 ACA
R20291 2 CCA Expected resistant Resistant (29)
R20291 1 TCA
phiMMP04 630 0 Expected sensitive Resistantd
R20291 1 CCG Expected sensitive Resistantd (29)
phiCDMH1 630 2 CCA Expected resistant ND
630 1 CTA
R20291 1 CCA Expected resistant ND
a For an allowed match between the CRISPR spacer and phage protospacer, we accepted up to five mismatches outside the potential “seed” region (first 8 nt of protospacer except
for position 6).
b The consensus PAM motif is CCA or CCT. Mismatches in this motif are shown in bold type.
c Phage sensitivity was examined by a phage infection spot assay (29). ND, not determined.
d Discrepancies between expected and observed resistance probably due to the existence of other resistance mechanisms. The complete genome sequences of Siphoviridae phages
phiCD24-1, phiCD111, and phiCD146 and Myoviridae phages phiCD481-1, phiCD505, phiCD506, phiMMP01, phiMMP03, and phiCD52 were deposited in European Nucleotide
Archive under accession no. LN681534, LN681535, LN681536, LN681538, LN681539, LN681540, LN681541, LN681542, and PRJEB7856, respectively. The complete genome sequence of
phiCD211 was deposited in European Nucleotide Archive under accession no. LN681537.
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supplemental material). Spacer sequences from strain R20291
contained more mismatches with phage sequences, including
multiple mismatches inside the potential “seed” region and non-
canonical PAMs in targeted protospacers (Table S3). These could
explain the sensitivity of strain R20291 toward at least three of the
phages tested: phiCD38-2, phiCD146, and phiCD481-1.
Of note, several CRISPR spacers from strain 630 targeted the
same phage. For example, eight different spacers within several
CRISPR arrays targeted the myophage phiCD27. Six of them
are leader-proximal spacers (first or second position) within their
respective CRISPR arrays, including the most highly expressed
CRISPR 4 and CRISPR 15 (Fig. 1A). This is consistent with the
resistant phenotype observed with phiCD27 (Table 1). In addi-
tion, some identical spacers targeted two other related
myophages, phiCD505 andphiMMP2 (Table 1; see Table S3 in the
supplemental material). The leader-proximal positions of these
spacers could reflect relatively recent expansion of the corre-
sponding CRISPR arrays. Another example of simultaneous tar-
geting by the overlapping set of CRISPR spacers from both 630
and R20291 strains is the targeting of three related Siphoviridae
phages phiCD38-2, phiCD111, and phiCD146 (Table S3).We also
observed the presence of several spacers within the same CRISPR
array that target the same phage, suggesting repeated interactions
between this C. difficile strain and the corresponding phage (Ta-
ble S3). This seems to be a general feature of C. difficile CRISPR
arrays observed for all nine analyzedC. difficile strains (Table S2C)
and may reflect a specific characteristic of interaction with phage,
such as primed spacer adaptation (37). In several cases, within
long CRISPR arrays (e.g., in M120 strain), spacers that were more
distal presented larger numbers of mismatches with phage se-
quences and/or were more frequently associated with noncanoni-
cal PAMs than leader-proximal spacers targeting the same phage
(Table S2C). For the phage genome hits, about half of the nonca-
nonical PAMs were associated with at least one mismatch within
the potential “seed” region, also suggesting a mutational process
to escape CRISPR defense.
Our analysis also revealed some discrepancies between ex-
pected and observed phage susceptibility phenotypes. The major-
ity of cases concern the phage sensitivity that could be predicted
while the phage resistance phenotype was observed. One opposite
example is the R20291 arrays containing spacers targeting
phiCD38-2 and phiCD146 phages. The mismatches inside the
“seed” or PAM region in some cases and the leader-distal position
of other spacers possibly associated with lower abundance and/or
stability of corresponding crRNAs could explain the observed sen-
sitivity of R20291 strain to phiCD38-2 and phiCD146 phages (Ta-
ble 1; see Table S3 in the supplemental material). The R20291
strain was resistant to infection by phiCD111, phiCD506, and
phiMMP04 (29). However, in each case, only one potential active
spacer was detected within CRISPR arrays of this strain, and a
noncanonical CCC or CCG PAM preceded the corresponding
protospacer within the phage genomes. Interestingly, these CCC/
CCGmotifs were also revealed as overrepresented alternativemo-
tifs by general analysis of protospacer-flanking regions (Ta-
ble S2B). This could suggest that a single mismatch within PAM
does not disturb the CRISPR-mediated interference, as observed
FIG 5 CRISPR spacer targeting of C. difficile phages. The CRISPR spacer hits are indicated by red flag symbols on the genomes of representative members of
clostridial phage groups: myophages phiMMP02 (for phiMMP02/phiCD505 group), phiCD27, phiCDHM1, phiMMP03 (for phiMMP01/phiMMP03 group),
phiC2, phiCD119, phiCD481-1 (for phiMMP04/phiCD481-1/phiCD506 group), phiCD211, and siphophages phiCD38-2 (for phiCD38-2/phiCD111/
phiCD146 group) and phiCD6356. Late phage genes (blue), early middle genes (pink), and integrase/resolvase genes (yellow) are indicated. One flag symbol
corresponds to either a single hit or multiple hits.
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for multiple PAMs in the Haloarchaeal CRISPR I-B system (26),
or that othermechanisms could be involved. Interestingly, despite
very similar CRISPR array contents in strains CD196 and R20291
of the PCR ribotype 027 (Fig. S3), there are apparent differences in
phage susceptibility profiles of these strains that could also be
explained by other, non-CRISPR, defense mechanisms. Similarly,
a homology search with CRISPR arrays in strain 630 revealed no
spacers targeting phiCD24-1, phiCD52, and phiMMP04, while
strain R20291 CRISPR arrays contained no spacers targeting
phiCD24-1 (Table 1). However, these strains were resistant to the
corresponding phages, likely due toCRISPR-independent defense
mechanisms.
To conclude, the phage infection assays support the function-
ality of the C. difficile CRISPR system for protection from phage
infection. Possible interference with resident prophages, differ-
ences in spacer efficiency, and the existence of other mechanisms
of phage resistance like receptor modifications and restriction/
modification systems could explain the observed discrepancies
with phage sensitivity predictions (12).
(iii) C. difficile cas genes function in CRISPR interference in
E. coli heterologous system. As a first step to mechanistic studies
of the C. difficile CRISPR-Cas system, we established a heterolo-
gous system in a surrogate E. coli host that had its own CRISPR-
Cas system removed. E. coli was chosen as a host that is easier to
manipulate genetically thanC. difficile. E. coli plasmids expressing
the conserved and complete cas operon from C. difficile strain 630
containing eight cas genes (CD2982-CD2975) were created. The
first part of the C. difficile cas operon (from CD2982 to CD2977
encoding the interference components) was cloned into the
pCDF-1b expression vector (pDIA6351), and the rest of the
operon (cas1 [CD2976] and cas2 [CD2975] genes) was cloned into
the pRSF-1b vector (pDIA6349) under the control of T7 RNA
polymerase (T7 RNAP) promoter. Next, E. coli host strains con-
taining minimized C. difficile CRISPR arrays were created. Se-
quences of the highly expressed C. difficile 630 CRISPR 12 or
CRISPR 16 arrays (Fig. 2; see Fig. S1 in the supplementalmaterial)
were selected for this purpose. The third “miniarray” containing
only the leader region with direct repeat but without the spacer
sequence was used as a negative control. These CRISPR arrays,
flanked by a T7 RNAP promoter and transcriptional terminator
sequences, were introduced into the genome of the E. coli BL21-
AI_CRISPR strain lacking endogenous cas genes and carrying
the T7 RNAP-encoding gene under the control of the arabinose-
inducible araBAD promoter (strains KD620, KD623, and KD626
[Table S4]). To monitor the CRISPR interference, strains KD620,
KD623, and KD626 harboring the C. difficile cas expression plas-
mids were transformed with the compatible pT7Blue-based plas-
mids containing the protospacer-matching spacers within
CRISPR “miniarrays.” Each strain was transformed with the
pT7Blue derivatives containing theCCAPAMfollowed by either a
protospacer perfectly matching the CRISPR spacer (pDIA6361 or
pDIA6363), a protospacer with a single mismatch at the first po-
sition (pDIA6362 or pDIA6364), or an empty control pT7Blue
vector (Table S4). Upon induction of C. difficile subtype I-B
CRISPR-Cas in E. coli in the presence of L-arabinose, we observed
a decrease in the transformation efficiency of plasmids containing
protospacers fully matching the CRISPR array spacers and no dif-
ference in the transformation efficiency with a control strain car-
FIG 6 PAM identification forCRISPR system inC. difficile. (A) The alignment of regions flanking protospacers targeted by theCRISPR systemwas used to create
the sequence logo byWebLogo for CRISPR spacers from strains 630 and R20291. The 5= PAM (protospacer adjacentmotif) at positions3,2, and1 relative
to the first position of the protospacer is indicated. The PAM 3-nucleotide WebLogo created on the basis of potential protospacer flanking regions from nine
C. difficile strains is shown below. (B) Efficiency of conjugation of pMTL84121-derived plasmids (carrying p15a Gram-negative bacterial replicon and pCD6
Gram-positive bacterial replicon) and pRPF185-derived plasmids (carrying ColE1 Gram-negative bacterial replicon and pCD6 Gram-positive bacterial repli-
con). Protospacer 1 CRISPR 16 mutation indicates a G-to-A substitution at the first position. The representative results of three independent experiments are
shown.
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rying a CRISPR array without a spacer. Mutation in the first po-
sition of the protospacer “seed” region abolished the observed
interference leading to the transformation efficiencies similar to
those obtained with the empty vector (Fig. 7).
The pDIA6351 plasmid carrying the first part of the operon
(cas6, cas8, cas7, cas5, cas3, and cas4 genes) lacking cas1 and cas2
genes was sufficient to observe the interference, and the presence
of both pDIA6349 and pDIA6351 plasmids carrying the entire cas
gene set did not lead to improved interference efficiency (data not
shown). A representative result obtained with the pDIA6351 plas-
mid is shown in Fig. 7. Together, these results confirm the func-
tionality of the C. difficile CRISPR system and demonstrate the
role of specific cas genes in the plasmid interference process.
DISCUSSION
C. difficile is an emergent human enteropathogen that must cope
with abundant bacteriophages and other exogenous genetic ele-
ments during its development inside the host. Horizontal gene
transfer would be beneficial for the acquisition of new adaptive
traits (38); however, foreign invaders could also cause damage.
Efficient defense systems could thus be important for C. difficile
during the interactionswith othermembers of the gutmicrobiota.
In the present paper, we demonstrate the functionality of C. diffi-
cile CRISPR system using plasmid conjugation efficiency assays
and interference assays in E. coli as a heterologous host. We show
that multiple CRISPR arrays in C. difficile strains carry specific
spacers that can be considered “memories” of past C. difficile en-
counters with foreign genetic elements, including clostridial
phages. In addition, our new phage genome sequences provide
essential information for detailed functional spacer analysis. Only
a fraction of spacers match known sequences, which suggests that
numerous other foreign invaders interact with C. difficile and re-
main to be discovered.
Our work provides evidence for an active bacterial CRISPR
system of subtype I-B. In agreement with findings for other
CRISPR type I systems, we show that a specific PAM sequence is
necessary for self and nonself discrimination for clostridial sys-
tems. In addition, the extent of spacer sequence matching the
targeted protospacer seems to be critical for CRISPR interference;
in particular, an exact match at the first position of the proto-
spacer is needed for CRISPR interference, as observed in other
systems (19, 34). We also provide experimental evidence for the
role of theC. difficileCas proteins in the interference process in the
heterologous host,E. coli. The universal CRISPR-Cas system com-
ponents Cas1 and Cas2 important for the adaptation process in
other bacterial systems (39, 40) seem to be dispensable for inter-
ference mediated by the C. difficile CRISPR-Cas I-B system.
The originality of the CRISPR-Cas system in C. difficile is the
presence of multiple active CRISPR arrays, which is in contrast to
the presence of silent or barely expressed CRISPR loci in some
other bacteria such as Streptococcus pyogenes and E. coli (41, 42).
Interestingly, we observed a similar bias on the transcriptional
FIG 7 Functionality of C. difficile cas genes for plasmid interference in E. coli. The transformation efficiency was estimated with pT7Blue derivative plasmids
carrying the wild-type (wt) protospacer corresponding to the first spacer of the CRISPR 16 array (CR16) (rows 2 and 5) or a mutated protospacer CR16 (rows 3
and 6) compared to the pT7Blue empty vector used as a negative control (rows 1 and 4). The protospacer plasmid used is indicated to the left of the photographs
together with schematic representation of E. coli strains carrying engineered CRISPR arrays with the corresponding spacer under the control of T7 RNAP
promoter (T7). E. coli KD623 strain (rows 1 to 3) carries C. difficile CRISPR “miniarray” with the first spacer of CRISPR 16 array flanked by repeats, and E. coli
KD626 strain (rows 4 to 6) carries reduced “miniarray” with one repeat lacking spacer sequence. The CRISPR “leader” region (LDR) is indicated. Both strains
were transformed with pCDF1-b vector derivative, allowing the expression of C. difficile cas gene set lacking cas1 and cas2 (from CD2982 to CD2977). The Cas
protein production and crRNA expression were induced by the addition of 1 mM L-arabinose and 1 mM IPTG. The serial dilutions of transformation mixtures
deposited on LB plates with ampicillin are indicated (ND, not diluted).
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orientation of CRISPR arrays in the direction of replication as a
previously reported strong coding bias for the leading strand of
the chromosome and GC skew (Fig. 1) (10, 43). This could reflect
selection for optimal CRISPR array orientation with respect to
chromosome replication as generally observed for the direction of
transcription of rRNA genes and other essential and/or highly
expressed bacterial genes (44–46). The results of analyzing the
CRISPRdb data for seven other C. difficile strains suggest general
transcriptional orientation for CRISPR arrays on a leading DNA
strand (data not shown). Only one array in both strains 630 and
R20291 is associated with a complete cas operon. The presence of
one or two additional incomplete cas operons composed of five
genes, including cas3, cas5, cas6, and cas7 in both strains, could
suggest their possible accessory role in CRISPR function. Less-
efficient interference in a surrogate host driven by themajor set of
C. difficile Cas proteins observed in E. coli can be also taken as
evidence for the requirement of other cas gene products (or addi-
tional C. difficile functions) for efficient interference.
To obtain a global view of the occurrence of cas operons in
C. difficile, we evaluated the presence of homologs of the two cas
operons CD2982-CD2975 and CD2455-CD2451 in the published
genomes of 2,207 C. difficile strains (see Table S5A in the supple-
mental material). We found that the majority of sequencedC. dif-
ficile strains contain both cas gene sets, the homologs of CD2982-
CD2975 cas locus being present in about 90% of strains, while the
homologs ofCD2455-CD2451 cas locuswere detected in almost all
strains analyzed. Interestingly, analysis of the MLSTs of strains
lacking the homologs of CD2982-CD2975 cas locus revealed a
strong correlation between the absence of the complete cas locus
and the MLST of C. difficile strains (Table S5B). This could reflect
an evolutionary history of cas gene loss or acquisition. The loss of
a CD2975-like locus seems to be extremely rare in the group of
strains belonging to MLST 3 (PCR ribotype 027 for the majority
of strains, including strainR20291) and 23. About half of strains of
MLST 19 and 25 lack this locus. In other MLST groups like MLST
9 and 45, the absence of the CD2975-like locus is frequently ob-
served (Table S5B). We have also analyzed the presence of an
additional partial cas operon homologous to the CDR20291_
2998-2994 operon from strain R20291. The nonrandom distribu-
tion according to the MLST groups was observed for this operon
as well. It was associated with the majority of the MLST 3 group,
including the PCR ribotype 027 strains, and absent in several
MLST groups likeMLST 19, 33, 39, and 49 (Table S5C). Thus, our
analysis showed a strong correlation between the evolutionary
relationships of theC. difficile strains and their CRISPR array con-
tent and cas operon occurrence. This may be related to the epide-
miological context of different C. difficile strains (isolation of the
strains), reflecting the intensity of their interactions with foreign
DNA elements.
The prophage localization of CRISPR arrays in several strains
and a large proportion of prophage targeting by CRISPR spacers
are other peculiarities of the C. difficile CRISPR system (30)
(Fig. 1A and Fig. 4; see Table S2 in the supplemental material).
These two factors raise questions about the role of such spacers in
preventing infection by other competing phages and the spread of
CRISPR arrays by horizontal gene transfer by lysogenic phages.
Our RNA-seq analysis demonstrated that some prophage-related
CRISPR RNAs were among the most abundant transcripts de-
tected in both strains 630 and R20291 (Fig. S1 and Fig. S2) (24).
Remarkably, none of the CRISPR arrays located within prophages
possess associated cas operons, indicating that these prophage-
related CRISPR arrays rely on a common Cas protein set encoded
by the host. In general, prophages have played an important role
in the evolution and virulence of pathogenic bacteria (47). Recent
data for C. difficile suggest that prophages can modulate the toxin
production, mediate the transmission of antibiotic resistance
genes between different strains, and influence the sporulation
process and bacterial gene regulation (33, 47, 48). In addition, the
phage-related pathogenicity locus (PaLoc) can be transferred by
transduction between C. difficile strains converting nontoxigenic
strains into toxin producers (49). In Vibrio cholerae, the existence
of a phage-encoded CRISPR system targeting a bacterial phage-
inhibitory locus was recently uncovered (50). Prophages within
C. difficile genomes could also influence the interactions with
other phages. The possible transfer of active CRISPR arrays be-
tween differentC. difficile strains would be important for bacterial
fitness within the gut environment, enriching the diversity of
spacers in the repertoire by acquisition of entire CRISPR arrays. In
relation to the C. difficile infection cycle, it is interesting to note
that stress conditions, including antibiotic treatments, could in-
duce prophages and lead to the release of phage particles and
infection of neighboring bacteria, thus contributing to the
CRISPR spreading within C. difficile populations (31). Together
with dysbiosis, this can increase the rigor of this pathogen.
The detailed comparison of CRISPR spacer homology to phage
sequences with corresponding phage resistance phenotypes pro-
vides important insights on CRISPR system function. The results
of this analysis revealed targeting by several spacers of the same
phage, which should increase the efficiency of CRISPR defense
and suggest a mutational process of the phage to escape the
CRISPR system or primed acquisition of spacers (or both). In
addition, some overrepresented spacers target conserved genes
within related phages leading to economical and efficient defense
against several phages. Recent long-term phage infection studies
in Streptococcus thermophilus showed preferential selection of spe-
cific highly represented spacers within bacterial populations, sug-
gesting enhanced defense capacities of the corresponding crRNA
based on location and effectiveness (51). The relatively high fre-
quency of noncanonical PAM sequences observed in our study
may suggest that single mismatches within PAM could be toler-
ated by the CRISPR I-B system, as previously suggested in studies
of archaeal systemswithmultiple PAMs as target interferencemo-
tifs and a reduced number of PAMs as spacer acquisition motifs
(19). Alternatively, other active defense mechanisms against
phages working independently against the CRISPR system (12)
could also interfere with C. difficile interactions with phages. It
should be noted that for the moment only temperate phages in-
fecting C. difficile have been isolated and tested in the present
study (29, 52). The possibility that in some cases, the apparent
phage resistance could be related to immunity conferred by re-
lated endogenous prophages due to the use of temperate phages
cannot be excluded.
In conclusion, this study significantly expands our knowledge
on C. difficile interactions with specific phages, highlighting spe-
cific features of CRISPR-Cas adaptive immune system in this im-
portant enteropathogen. Numerous actively expressed CRISPR
arrays might provide C. difficile strains with the extended defense
capacities against foreign invaders, including phages abundant
within the gut communities. Further studies on the role of
Boudry et al.
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CRISPR system during infection will bring light on these impor-
tant aspects of C. difficile adaptation inside the host.
MATERIALS AND METHODS
Plasmid and bacterial strain construction and growth conditions.
C. difficile and E. coli strains and plasmids used in this study together with
detailed descriptions of plasmid and bacterial strain construction are pre-
sented in Table S4 in the supplemental material. C. difficile strains were
grown anaerobically (5% H2, 5% CO2, and 90% N2) in TY (53) or brain
heart infusion (BHI) (Difco) medium in an anaerobic chamber (Ja-
comex). When necessary, cefoxitin (Cfx) (25 g·ml1) and thiampheni-
col (Tm) (15 g·ml1) were added to C. difficile cultures. E. coli strains
were grown in LBbroth (54), andwhenneeded, ampicillin (100g·ml1),
chloramphenicol (15 g·ml1), tetracycline (15 g·ml1), kanamycin
(50 g·ml1), or streptomycin (50 g·ml1) was added to the culture
medium. All primers used in this study are listed in Table S6.
RNA-seq analysis. Total RNA was isolated from late-exponential-
growth-phase cultures (grown for 6 h) of C. difficile R20291 grown in TY
medium as previously described (55), andmRNAwas enriched from total
RNA using MicrobExpress kit (Ambion). Nonoriented RNA-seq library
construction was performed with the TruSeq RNA sample prep kit from
Illumina as previously described (56) and subjected to Illumina HiSeq
2000 sequencing.
In silico analysis of CRISPR array spacer content and cas locus.
CRISPRdb tools (11), the CRISPRTarget program (28), or BLASTN (27)
were used for spacer homology search in the available sequences (April
2015). Several potential CRISPR arrays predicted byCRISPRdbwithin the
tcdA coding region were excluded from further analysis for the following
reasons: (i) their location within the toxin-encoding genes in all analyzed
C. difficile strains as a part of the cell wall-binding repeat regionswithin the
TcdA amino acid sequence; (ii) the prediction of the corresponding arrays
as “questionable sequences” by the CRISPRdb program for several ana-
lyzed C. difficile strains; (iii) the absence of a characteristic RNA-seq pro-
file for CRISPR arrays within the tcdA coding region; (iv) the absence of
potential targeting of corresponding spacers for the known sequences; (v)
the differences in the length and sequence of associated direct repeats with
those of active CRISPR arrays. Thus, in such particular cases, the
CRISPRdb predictions within repeated coding regions should be consid-
ered with caution and would need experimental confirmation.
For general CRISPR spacer homology search, the sequences presented
7 single nucleotide polymorphisms (SNPs) (80%match or30/37 nu-
cleotides) were considered positive hits. The raw sequencing read data of
published genome sequences from 2,207 C. difficile strains (57–62) were
used to search for the presence of cas loci homologous to the CD2982-
CD2975 and CD2455-CD2451 cas operons from strain 630 and the
CDR20291_2998-2994 operon from strain R20291. For each strain, the
sequencing reads were mapped on the sequence of corresponding cas
locus using Bowtie (63). Coverage values of80% were considered pos-
itive hits for the presence of corresponding cas loci in a given strain. The
multilocus sequence typing (MLST) scheme of Lemee et al. (64) has also
been inferred from raw sequencing read data.
Phage infection assays. Phage host range determination was done as
previously described (29) using spot tests with diluted phage lysates and
exponentially grown C. difficile cultures.
Plasmid conjugation efficiency assays. Derivatives of pMTL84121
and pRPF185 plasmids used to estimate the conjugation efficiency were
transformed into the E. coli HB101 (RP4) and subsequently mated with
C. difficile 630ermmutant strain on BHI agar plates for 24 h at 37°C. The
proportion of C. difficile transconjugants was estimated by subculturing
the cell conjugation mixture on BHI agar containing Tm (15 g·ml1)
and Cfx (25 g·ml1) and comparing the number of CFU obtained after
plating serial dilutions on BHI agar plates with Cfx lacking Tm.
Plasmid-based interference assays in E. coli. The transformation ef-
ficiency of pT7Blue derivative plasmids (see Table S4 in the supplemental
material) was monitored with E. coli strains lacking endogenous cas genes
and carryingC. difficileCRISPR “miniarray” within their genome, includ-
ing a CRISPR spacer targeting pT7Blue constructs and the plasmids
pRSF-1b and/or pCDF-1B expressing C. difficile cas genes under the con-
trol of T7 RNAP promoter. Cas protein and crRNA production was in-
duced with 0.5 to 1 mM L-arabinose and 1 mM isopropyl--D-
thiogalactopyranoside (IPTG), and electrocompetent cells were prepared
under these inducing conditions. Plasmids were then introduced by elec-
troporation, and undiluted and serially diluted aliquots of the transfor-
mationmixture were spotted on LB agar plates containing ampicillin and
either streptomycin or kanamycin/streptomycin to measure the transfor-
mation efficiency.
Data access. The complete genome sequences of phiCD24-1,
phiCD111, phiCD146, phiCD211, phiCD481-1, phiCD505, phiCD506,
phiMMP01, phiMMP03, and phiCD52 were deposited in EMBL-EBI da-
tabase under accession no. LN681534, LN681535, LN681536, LN681537,
LN681538, LN681539, LN681540, LN681541, LN681542, and
PRJEB7856, respectively. RNA-seq coverage visualizations of the CRISPR
loci are available for strain 630 through https://mmonot.eu/
COV2HTML/visualisation.php?str_id-17 and for strain R20291
through http://mmonot.eu/COV2HTML/visualisation.php?str_id-18
(65).
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